Read about Tarceva's common side effects and how they may be managed.
Tarceva Access Solutions provides coverage and reimbursement support, patient assistance and informational resources for both health care providers and their patients.
Watch an oncologist explain treatment options and information for patients taking Tarceva in combination with gemcitabine.
The topics in the Caregiver Support were created especially for you to help you learn about Tarceva basics, how to communicate with the patient and with others, ways to help ease the patient's daily life, and ways to care for yourself. You'll also find resource links and information on insurance coverage matters you may be helping to manage.
TARCEVA (erlotinib)in combination with gemcitabine is indicated for the first-line treatment of patients with locally advanced, unresectable or metastatic pancreatic cancer.
This site is intended for US residents only.
© 2008 Genentech USA, Inc. and OSI Pharmaceuticals, Inc. All rights reserved.
TARCEVA®, its logo mark and 
are trademarks of OSI Pharmaceuticals, Inc.
Patients & CaregiversTarceva for Advanced Pancreatic Cancer |
Tarceva Access Solutions™ can help.
888-249-4918
script language="JavaScript" src="/inc/dw_tooltip.js" type="text/javascript">
